BioLAGO organises "Robotics-4-Labautomation" symposium in Konstanz, Germany
This event will gather experts in robotics and the automation of research, and the pharmaceutical and healthcare industry who wish to network and exchange ideas with scientists and industry representatives from across Europe.
See the full programme: Symposium Robotics-4-Labautomation
Our colleague Anthony Remazeilles, Technical and Science Manager of TraceBot, will present key developments, including collaborative arm control, dexterous manipulation, perception and digital twin technology, as well as audit trail generation.
- Current issues around robotics and automation in the pharmaceutical and healthcare industries will be discussed.
- Inspiring talks will address the issues of sterility in the laboratory, and the challenges and requirements when integrating a robot into a laboratory automation system.
- Object identification, robotic sensors and AI interaction, and digital twins.
- Aspects of quality management and validation of robotic systems in the pharmaceutical industry and in diagnostics will be discussed at a round table.
- The symposium will conclude with an overview of the main current trends in automation and robotics: which are the most important research areas of the future?
TraceBot
The event is part of the TraceBot project, which receives funding from the European Union’s H2020-EU.2.1.1 programme. The aim is to develop laboratory robots that meet the traceability criterion and are therefore suitable for use in laboratory environments, as well as in other fields of application with high safety and flexibility requirements.
Project partners will be present at the symposium.
What is BioLAGO?
BioLAGO is the largest cross-border health network in the region of the four countries bordering Lake Constance: Germany, Switzerland, Austria and Liechtenstein. The network links business and science for innovation. It addresses high-tech sectors of the healthcare industry: medical technology, diagnostics, bioinformatics and pharmaceuticals, including personalised medicine, often referred to as the 4Ds of medicine: devices, diagnostics, data, drugs.